Please enable Javascript on your browser for a better experience.
The GGT Test measures gamma-glutamyl transferase, an enzyme found in the liver and bile ducts, to evaluate liver health. Elevated GGT may indicate liver disease, bile duct obstruction, alcohol use, or medication side effects. Doctors order this test to investigate symptoms like fatigue, jaundice, dark urine, or abdominal pain and to monitor liver damage. It is often performed with other liver tests to provide a complete picture of liver and bile duct function.
The Medication Safety, Balance & Clearance Panel evaluates how medications affect the body using a Comprehensive Metabolic Panel (CMP), Complete Blood Count (CBC), Cystatin C, Magnesium, and Gamma-Glutamyl Transferase (GGT). These tests help monitor kidney clearance, liver stress, hydration, electrolyte balance, and blood health, which are key factors in medication safety, fall risk, and drug buildup.
Medication Safety Core Panel, Medication Processing & Safety Panel, Medication Balance & Organ Health Panel, Medication Safety Baseline Panel, Medication Clearance & Balance Check
Evaluate metabolic health and insulin sensitivity with the Visceral Fat and Insulin Resistance Panel. This panel includes glucose, insulin, lipid, inflammation, and liver markers to provide insight into visceral fat related metabolic function, energy regulation, and cardiometabolic risk factors.
The Gallbladder & Digestive Health Panel evaluates key biomarkers associated with liver function, gallbladder activity, pancreatic enzymes, inflammation, and metabolic health. By combining the Comprehensive Metabolic Panel, GGT, lipase, amylase, CBC, CRP, and a lipid panel, this test provides a broad laboratory assessment of digestive system function and helps support clinical evaluation of symptoms that may involve the liver, pancreas, or biliary system.